NCT04127110
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04127110 |
| Title | Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients (ALKALINE) |
| Acronym | ALKALINE |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | European Organisation for Research and Treatment of Cancer - EORTC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NOR | NLD | GBR | FRA | ESP | BEL |
CKB BOOST